Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 12, 2010

View Archived Issues

Electroporation can increase the efficacy of DNA vaccination for prostate cancer

MMP12 polymorphism linked to asthma and chronic obstructive pulmonary disease

Novel ER alpha and beta ligands discovered by Czech scientists

InNexus Biotechnology develops new skin-permeating psoriasis product

FDA grants fast track designation to Sopherion Therapeutics' Myocet in breast cancer

Miraculins and Inverness to collaborate on diagnostic test for pre-eclampsia

Reata and Kyowa Hakko Kirin sign licensing agreement for CKD drug bardoxolone

FDA grants marketing approval to Hi-Tech Pharmacal's Tropazone dermatitis treatment

Pfizer and Debiopharm to initiate phase III trial of tremelimumab in stage IV melanoma

Amira develops solid-dose formulations of FLAP inhibitors

FDA approves Chugai's monoclonal antibody Actemra for moderate to severe RA

Sanofi and KaloBios sign agreement for Humaneered antibody for P. aeruginosa

FDA grants orphan drug designation to Clavis's CP-4126 for pancreatic cancer

Boston Scientific granted Japanese marketing approval for Promus coronary stent system

Delay in FDA review of MannKind's NDA for Afrezza

Study determines pharmacokinetics of HCV candidate ABT-333 in infected patients

Hepatitis C treatment SPC-3649 to enter phase II investigation this year

In vitro data clarify mechanism of action of HCV candidate ATI-0810

AstraZeneca claims fumarate salts of ErbB kinase inhibitors for cancer therapy

Budesonide derivatives presented by Auspex Pharmaceuticals

Celgene describes novel thioxoisoidoline compounds for the treatment of cancer

GSK discloses novel prostanoid EP4 receptor agonists for pain, bone disorders

TetraLogic commences phase I TL-32711 trial in solid tumors or lymphoma

First patient dosed in phase III PLX-4032 trial in metastatic melanoma

Funxional Therapeutics completes phase I FX-125L program

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...